• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于兽用狂犬病疫苗生产的狂犬病病毒灭活剂双乙基亚胺的验证。

Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production.

作者信息

Mondal S K, Neelima M, Seetha Rama Reddy K, Ananda Rao K, Srinivasan V A

机构信息

Indian Immunologicals Limited, Gachibowli, Hyderabad 500 019, India.

出版信息

Biologicals. 2005 Sep;33(3):185-9. doi: 10.1016/j.biologicals.2005.05.003.

DOI:10.1016/j.biologicals.2005.05.003
PMID:16084736
Abstract

The rabies vaccine is produced by inactivation of rabies virus propagated on BHK21 cells. In the rabies inactivation process, BEI is added at a final concentration of 1.6 mM to the viral harvest at 37 degrees C, followed by a second dose of BEI at 24 h post-inactivation. Inactivation was confirmed by the mice innocuity test and tissue culture amplification test as per B.P (Vet) 2004. Validation of test procedure is essential as per cGMP requirement. The dose of BEI was validated by using lower and higher concentrations of BEI in inactivation process. The study indicated that BEI at a lower concentration (0.4 mM) was able to inactivate the rabies virus within 30 h and the routine concentration (1.6 mM) of BEI is effective in inactivating rabies virus within 18 h. The amplification test used for confirming the inactivation of the live virus was validated by spiking the sample with different dilutions of pretitrated live rabies virus. The test revealed that the amplification method is sensitive to detect live rabies virus if present in the inactivated sample. The validation of BEI as an inactivant and the amplification test are discussed.

摘要

狂犬病疫苗是通过对在BHK21细胞上繁殖的狂犬病病毒进行灭活来生产的。在狂犬病灭活过程中,在37摄氏度下向收获的病毒中加入终浓度为1.6 mM的β-丙内酯(BEI),灭活后24小时再加入一剂BEI。根据《英国药典(兽医)》2004版,通过小鼠无害试验和组织培养扩增试验确认灭活效果。按照药品生产质量管理规范(cGMP)要求,对试验程序进行验证至关重要。在灭活过程中使用较低和较高浓度的BEI对BEI的剂量进行了验证。研究表明,较低浓度(0.4 mM)的BEI能够在30小时内灭活狂犬病病毒,常规浓度(1.6 mM)的BEI能在18小时内有效灭活狂犬病病毒。用于确认活病毒灭活的扩增试验通过向样品中加入不同稀释度的预先滴定的活狂犬病病毒进行了验证。试验表明,如果灭活样品中存在活狂犬病病毒,该扩增方法对其检测很敏感。文中讨论了BEI作为灭活剂的验证以及扩增试验。

相似文献

1
Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production.用于兽用狂犬病疫苗生产的狂犬病病毒灭活剂双乙基亚胺的验证。
Biologicals. 2005 Sep;33(3):185-9. doi: 10.1016/j.biologicals.2005.05.003.
2
Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccine.用作口蹄疫组织培养疫苗灭活剂的双乙烯亚胺(BEI)的验证
Biologicals. 2004 Sep;32(3):153-6. doi: 10.1016/j.biologicals.2004.09.001.
3
Rabies virus inactivation by binary ethylenimine: new method for inactivated vaccine production.用双乙撑亚胺灭活狂犬病病毒:生产灭活疫苗的新方法。
J Clin Microbiol. 1980 Feb;11(2):120-2. doi: 10.1128/jcm.11.2.120-122.1980.
4
Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus.
Res Vet Sci. 2008 Dec;85(3):589-94. doi: 10.1016/j.rvsc.2007.12.009. Epub 2008 Feb 8.
5
Vero-cell rabies vaccine produced using serum-free medium.使用无血清培养基生产的Vero细胞狂犬病疫苗。
Vaccine. 2004 Dec 9;23(4):511-7. doi: 10.1016/j.vaccine.2004.06.014.
6
Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.通过二乙烯亚胺和甲醛的组合实现口蹄疫病毒和肠道病毒的极快速(且安全)灭活。
Dev Biol (Basel). 2004;119:449-55.
7
Validation of a binary ethylenimine (BEI) inactivation procedure for biosafety treatment of foot-and-mouth disease viruses (FMDV), vesicular stomatitis viruses (VSV), and swine vesicular disease virus (SVDV).验证一种用于口蹄疫病毒(FMDV)、水疱性口炎病毒(VSV)和猪水疱病病毒(SVDV)生物安全处理的双乙烯亚胺(BEI)灭活程序。
Vet Microbiol. 2021 Jan;252:108928. doi: 10.1016/j.vetmic.2020.108928. Epub 2020 Nov 16.
8
Standardization of methods used for testing the safety of tissue culture rabies vaccines.用于检测组织培养狂犬病疫苗安全性的方法的标准化。
Dev Biol Stand. 1978;40:209-13.
9
Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.优化病毒产量作为提高生物反应器中Vero细胞狂犬病疫苗产量的策略。
J Biotechnol. 2006 Jan 24;121(2):261-71. doi: 10.1016/j.jbiotec.2005.07.018. Epub 2005 Sep 8.
10
Protection of Procambarus clarkii against white spot syndrome virus using inactivated WSSV.利用灭活的白斑综合征病毒保护克氏原螯虾抵御白斑综合征病毒。
Fish Shellfish Immunol. 2009 May;26(5):685-90. doi: 10.1016/j.fsi.2009.02.022. Epub 2009 Mar 4.

引用本文的文献

1
Preparation of an Inactivated Peste des Petits Ruminants Vaccine and Its Comparative Immunogenicity Evaluation in an Animal Model.制备一种小反刍兽疫灭活疫苗及其在动物模型中的免疫原性比较评价。
Arch Razi Inst. 2021 Oct 31;76(4):731-739. doi: 10.22092/ari.2020.351398.1523. eCollection 2021 Oct.
2
Immunogenicity of an inactivated rabies vaccine for animals derived from the recombinant ERAGS strain.源自重组ERAGS株的动物用狂犬病灭活疫苗的免疫原性。
Clin Exp Vaccine Res. 2021 May;10(2):141-147. doi: 10.7774/cevr.2021.10.2.141. Epub 2021 May 31.
3
Efficacy of inactivated velogenic Newcastle disease virus genotype VII vaccine in broiler chickens.
速发型新城疫病毒VII型灭活疫苗对肉鸡的效力
Vet Res Forum. 2020 Spring;11(2):113-120. doi: 10.30466/vrf.2019.95311.2295. Epub 2020 Jun 15.
4
The efficacy of binary ethylenimine-inactivated vaccines of Gianyar-1/AK/2014 virulent strain in protecting chickens against Tabanan-1/ARP/2017 virulent Newcastle disease virus isolates.吉安雅尔-1/AK/2014强毒株二元乙撑亚胺灭活疫苗对鸡抵御塔巴南-1/ARP/2017强毒株新城疫病毒分离株的效力。
Vet World. 2019 Jun;12(6):758-764. doi: 10.14202/vetworld.2019.758-764. Epub 2019 Jun 8.
5
Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.Balb/c小鼠对在BHK-21细胞中繁殖的巴厘岛狂犬病病毒分离株的保护性抗体反应。
J Vet Med Sci. 2018 Nov 1;80(10):1596-1603. doi: 10.1292/jvms.17-0385. Epub 2018 Sep 11.